Follow
Biomarker Discovery
Biomarker Discovery is a process in which molecular substances in the body are used to indicate health or disease. One of the biggest challenges in biomarker discovery is the difficulty of identifying medium to low abundance proteins in complex biological samples.
-
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...DEC 02, 2025 | 8:00 AM
Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor. Conventional clinical assessments and imaging often miss the early mol...DEC 10, 2025 | 2:00 PM
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...DEC 10, 2025 | 8:00 AM
Mass spectrometry (MS)-based proteomic biomarker discovery pipeline commonly begins with large-scale profiling techniques detecting thousands of candidate biomarkers. Efficiently triaging th...OCT 28, 2025 | 7:00 AMC.E. CREDITS
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature...Speaker: Alison Cheung, PhD , Colinda Scheele, PhD , Andrea Radtke, PhDSponsored By: Leica MicrosystemsOCT 21, 2025 | 9:00 AM
Plasma proteomics offers great promise for biomarker discovery, due to the accessibility and diagnostic relevance of blood plasma. Recent advances in instrumentation, particularly the Orbitr...OCT 01, 2025 | 9:00 AM
Our experience collaborating with oncology and immunology leaders in the pharmaceutical and biotech space has revealed the numerous challenges in every stage of drug development. From target...Speaker: Sathiya Manivannan
SEP 17, 2025 | 8:00 AM
Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights....
SEP 17, 2025 | 10:00 AM
Antibody reactome profiling is a powerful approach for analyzing antibody-antigen interactions at scale, offering a comprehensive view of an individual’s immune history and current imm...
Speaker:
Linda Kusner, PhD
, Kathryn (Katy) Shaw-Saliba, ScM, PhD
, Jessica Lasky-Su, ScD
Sponsored By: Infinity Bio
SEP 10, 2025 | 11:00 AM
Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minima...
JUL 31, 2025 | 8:00 AM
C.E. CREDITS
Explore the insights shared at ASHG 2024 on MVP-ROAR and AutoMitoC—now available on-demand. This Educational Session underscores the value of healthcare-linked biobanks and computation...
July 31, 2025 7am PST/10am EST/4pm CET
microRNAs are emerging as powerful biomarkers for precision medicine, offering valuable insights into disease mechanisms, diagnosis, prognosis, and treatment response. However, successful di...
JUL 16, 2025 | 8:00 AM
The identification of reliable biomarkers from peripheral blood is crucial for improving disease diagnosis and monitoring. Spectral flow cytometry has emerged as a powerful tool for high-dim...
JUN 17, 2025 | 8:00 AM
Join Alamar Biosciences for an expert-led webinar exploring how emerging proteomics technologies—like NULISAseq™ high-sensitivity, multiplexed assays—are enabling more prec...
JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...
JUN 10, 2025 | 6:00 AM
Personalized health profiling using multi-omics data has the potential to reveal immunometabolic disruptions among individuals living with HIV (PWH) who are effectively undergoing antiretrov...
MAY 28, 2025 | 8:00 AM
Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, me...
MAY 15, 2025 | 9:00 AM
The immune system is dynamic and multifaceted, making the discovery of meaningful biomarkers and the study of disease a significant challenge. The leadership at Talon Biomarkers has a long h...
FEB 26, 2025 | 8:00 AM
Dr. Fraser's research is focused on the discovery and validation of diagnostic and prognostic biomarkers for complex diseases, including renal dysfunction, long-COVID, and sepsis. By leverag...
FEB 13, 2025 | 7:00 AM
Using next-generation proteomics technologies, organoid-based research models have the potential to revolutionize drug discovery and personalized medicine, improving our understanding of neu...
FEB 04, 2025 | 7:00 AM
C.E. CREDITS
Protein biomarker discovery, validation and utilization require technologies that deliver proteome insights with breadth and depth. Liquid chromatography mass spectrometry (LC-MS), the gold-...
Speaker:
Hanno Steen, PhD.
, Ann-Christine König, PhD.
, Jochen Schwenk, PhD
Sponsored By: Olink Proteomics
JAN 15, 2025 | 7:00 AM
Grab your cup of coffee and join us for the next Multiomics Coffee Break on 15th January at 10.00AM EST/4.00PM CET, with a presentation from Discovery Life Sciences, an Olink Certified Servi...
DEC 11, 2024 | 8:00 AM
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...
DEC 02, 2025 | 8:00 AM
Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor. Conventional clinical assessments and imaging often miss the early mol...
DEC 10, 2025 | 2:00 PM
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
DEC 10, 2025 | 8:00 AM
Mass spectrometry (MS)-based proteomic biomarker discovery pipeline commonly begins with large-scale profiling techniques detecting thousands of candidate biomarkers. Efficiently triaging th...
OCT 28, 2025 | 7:00 AM
C.E. CREDITS
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature...
Speaker:
Alison Cheung, PhD
, Colinda Scheele, PhD
, Andrea Radtke, PhD
Sponsored By: Leica Microsystems
OCT 21, 2025 | 9:00 AM
Plasma proteomics offers great promise for biomarker discovery, due to the accessibility and diagnostic relevance of blood plasma. Recent advances in instrumentation, particularly the Orbitr...
OCT 01, 2025 | 9:00 AM
Our experience collaborating with oncology and immunology leaders in the pharmaceutical and biotech space has revealed the numerous challenges in every stage of drug development. From target...
Speaker:
Sathiya Manivannan
SEP 17, 2025 | 8:00 AM
Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights....
SEP 17, 2025 | 10:00 AM
Antibody reactome profiling is a powerful approach for analyzing antibody-antigen interactions at scale, offering a comprehensive view of an individual’s immune history and current imm...
Speaker:
Linda Kusner, PhD
, Kathryn (Katy) Shaw-Saliba, ScM, PhD
, Jessica Lasky-Su, ScD
Sponsored By: Infinity Bio
SEP 10, 2025 | 11:00 AM
Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minima...
JUL 31, 2025 | 8:00 AM
C.E. CREDITS
Explore the insights shared at ASHG 2024 on MVP-ROAR and AutoMitoC—now available on-demand. This Educational Session underscores the value of healthcare-linked biobanks and computation...
July 31, 2025 7am PST/10am EST/4pm CET
microRNAs are emerging as powerful biomarkers for precision medicine, offering valuable insights into disease mechanisms, diagnosis, prognosis, and treatment response. However, successful di...
JUL 16, 2025 | 8:00 AM
The identification of reliable biomarkers from peripheral blood is crucial for improving disease diagnosis and monitoring. Spectral flow cytometry has emerged as a powerful tool for high-dim...
JUN 17, 2025 | 8:00 AM
Join Alamar Biosciences for an expert-led webinar exploring how emerging proteomics technologies—like NULISAseq™ high-sensitivity, multiplexed assays—are enabling more prec...
JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...
JUN 10, 2025 | 6:00 AM
Personalized health profiling using multi-omics data has the potential to reveal immunometabolic disruptions among individuals living with HIV (PWH) who are effectively undergoing antiretrov...
MAY 28, 2025 | 8:00 AM
Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, me...
MAY 15, 2025 | 9:00 AM
The immune system is dynamic and multifaceted, making the discovery of meaningful biomarkers and the study of disease a significant challenge. The leadership at Talon Biomarkers has a long h...
FEB 26, 2025 | 8:00 AM
Dr. Fraser's research is focused on the discovery and validation of diagnostic and prognostic biomarkers for complex diseases, including renal dysfunction, long-COVID, and sepsis. By leverag...
FEB 13, 2025 | 7:00 AM
Using next-generation proteomics technologies, organoid-based research models have the potential to revolutionize drug discovery and personalized medicine, improving our understanding of neu...
FEB 04, 2025 | 7:00 AM
C.E. CREDITS
Protein biomarker discovery, validation and utilization require technologies that deliver proteome insights with breadth and depth. Liquid chromatography mass spectrometry (LC-MS), the gold-...
Speaker:
Hanno Steen, PhD.
, Ann-Christine König, PhD.
, Jochen Schwenk, PhD
Sponsored By: Olink Proteomics
JAN 15, 2025 | 7:00 AM
Grab your cup of coffee and join us for the next Multiomics Coffee Break on 15th January at 10.00AM EST/4.00PM CET, with a presentation from Discovery Life Sciences, an Olink Certified Servi...
DEC 11, 2024 | 8:00 AM
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...